1 The built-bed splice bed was built under the full-light conditions of the exposed area, and it was made of bricks to make a 1.2-1.5m wide slotting machine, depending on the size of the long view, the water pipe with mist nozzles was erected on the plug bed. 2 Substratum is laid with 30cm thick pebbles or pebbles, and the upper layer is covered with coarse sand 20-30cm, and then sprayed with 0? 2% potassium permanganate solution. 3 Cutting preparations The first and second branches of non-woody jujube were collected in June and July. The ear cutting time is best at 8 o'clock in the morning. If it needs long-distance transportation, it will be magnified and immersed in the clear water immediately after harvesting, and then put into a shaded plastic bag. Immediately after the return, it will be cut into small pieces of 15-20 cm, and the upper leaves will be retained. , Remove the lower 3-5cm segment of young leaves, soak 50 minutes and put 500mg of carbendazim in 800-fold solution for 5 minutes, then use 300PPM of D-type rooting powder and 300PPM of C-type rooting agent to cut the base for 10 seconds. After the bell is removed, it is cut into 2*3CM rows at a distance of 2-3cm. 4 Immediately after the insertion, the full-light intermittent misting device shall be activated. Before the rooting, the spraying interval time shall be short to keep the foliage with a layer of water film. After rooting, it shall be sprayed once every day for 20-30 minutes and once for 1-2 hours at night. . The spraying time is extended 6 days before transplanting, usually 40-60 minutes. About 15 days after the insertion, a foliar dressing (0?2% urea solution) was performed, and 50% carbendazim was sprayed once a week for 1000 times. 5 The use of this technology can make the rooting rate of jujube more than 93%, 9-10 days after the insertion of callus production, 15 days to begin rooting. It is an advanced technology for implementing rapid propagation of excellent jujube varieties. China Agricultural Network Editor
[Eligibles]
Susceptible individuals and persons liable to be afflicted with the associated complications, such as children, elderly persons and individuals in the epidemic area.
[Function and use]
The product can induce immunity against influenza virus in recipients following immunization. It is used to prevent the infections of the prevalent strains of influenza viruses.
[Description]
The Influenza Vaccine (split virion) is a preparation made from the WHO recommended prevalent strains of influenza virus type A and type B, which are grown separately in embryonated chicken eggs. After incubation, the virus suspensions in allantoic cavities are harvested. The vaccine is prepared by inactivation, concentration, purification and disruption of the virus. It is a slightly milky-white liquid, containing thimerosal as a preservative.
Active constituent: Influenza haemagglutinin derived from each of prevalent influenza virus strains in that very year. (The name of each of virus strains and the content of haemagglutinin shall be included. )
Subsidiary materials: All the components of subsidiary materials approved shall be listed.
Vial
Pre-filled syringe
1.influenza vaccine
2.split virion
3.WHO recommended strains
4.against influenza virus
Influenza Vaccine
Influenza Vaccine,Inactivated Vaccine,Flu Vaccine,Influenza Vaccine For Human
Changchun Changsheng Life Sciences Ltd. , http://www.ccls-vaccine.com